One-of-a-kind U.S. research facility to advance testing, vaccines against global threats MANHATTAN — National Bio and Agro-Defense Facility researcher Lisa Hensley’s career took her from laboratory to laboratory and country to country to study the alphabet soup of ghastly pathogens such as SARs, monkeypox, MERs and Marburg. But she said an Ebola outbreak in the West Africa country of Liberia brought home what it meant to be in a country with a health-care system overwhelmed by a disease carrying a high mortality rate, without readily available treatment and vaccination options, and complicated by distorted public attitudes about the threat. “Their...